Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a short talk therapy tame PTSD in those who save lives?

NCT ID NCT05751473

Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether a brief form of talk therapy, called Prolonged Exposure for Primary Care (PE-PC), can reduce PTSD symptoms in first responders and frontline healthcare workers. Participants receive 4-6 weekly 30-minute sessions either by telehealth or in person, delivered by counselors in employee assistance programs. The goal is to see if this condensed therapy works better than the usual care offered through these workplace programs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Prolonged Exposure for Primary Care (PE-PC) talk therapy
What this could lead to
If effective, this brief therapy could provide a practical, accessible way to reduce PTSD symptoms in first responders and healthcare workers through workplace programs.
What could go wrong
This is a relatively small trial testing a condensed therapy format, and results may not apply to all workers or settings. The therapy may not work for everyone, and some participants may need more intensive treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 410 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are employees at an orginization served by a participating EAP * Have a Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5) score ≥33 * Have had psychotropic medication stability for at least 4 weeks Inclusion criteria for the qualitative portion of the study: \- Enrolled into the randomized clinical trial and were a treatment responder or were a treatment non-responder Exclusion Criteria: * Severe cognitive impairment that in the judgment of the investigators makes it unlikely that the participant can adhere to the study regimen (as evidenced by confusion, inability to track discussion or answer questions, or other clear and significant indicators of cognitive impairment) * High risk of suicide (defined as meeting criteria for Action Step 3 on the Participant Suicide Risk Screening form: found in protocol) * Need for detoxification * Active psychosis or unmanaged bipolar disorder, as measured by items 12 and 13 of the cross cutting assessment * Currently engagement in a trauma-focused behavioral treatment (such as Prolonged Exposure or Cognitive Processing Therapy). * Patients who do not speak English will be excluded for logistical reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-traumatic stress disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cope NewYork-Presbyterian

    RECRUITING

    New York, New York, 10017, United States

  • Detroit Fire Department

    RECRUITING

    Detroit, Michigan, 48226, United States

  • Duke University Health System

    RECRUITING

    Durham, North Carolina, 27705, United States

  • Health Management Systems of America

    RECRUITING

    Detroit, Michigan, 48226, United States

  • Henry Ford Health System

    ACTIVE_NOT_RECRUITING

    Detroit, Michigan, 48202, United States

  • Houston Fire Department

    RECRUITING

    Houston, Texas, 77002, United States

  • Michigan State University

    RECRUITING

    East Lansing, Michigan, 48824-1037, United States

  • ProMedica

    RECRUITING

    Fremont, Ohio, 43420, United States

  • Rutgers Health

    RECRUITING

    Piscataway, New Jersey, 08854, United States

  • Sharp Healthcare

    WITHDRAWN

    San Diego, California, 92129, United States

  • Tanner Health System

    RECRUITING

    Carrollton, Georgia, 30117, United States

  • University of Cincinati Health

    NOT_YET_RECRUITING

    Cincinnati, Ohio, 45229, United States

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • West Bloomfield Fire Department

    ACTIVE_NOT_RECRUITING

    West Bloomfield, Michigan, 48322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.